Author
David R. Liljenquist
Also Known As
B. Horowitz, Barbara Ritchey, Christina Peterson, D. Liljenquist, D. R. Liljenquist, DAVID R. LILJENQUIST, David Liljenquist, David R Liljenquist, David R. Liljenquist, Hirsch, Irl B.
50
Publications
4K
Citations
25
H-Index
22
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 6 | 6 | 642 |
2 | Diabetes | 5 | 5 | 615 |
3 | Public Health | 4 | 4 | 496 |
4 | Biostatistics | 1 | 1 | 12 |
5 | Exercise Physiology | 1 | 1 | 12 |
David R. Liljenquist
×
24
Publications
3.3K
Citations
21
H-Index
| Year | Citations | |
|---|---|---|
2006 | 701 | |
2020 | 400 | |
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial Paresh Dandona, Chantal Mathieu, Moshe Phillip, The Lancet Diabetes & Endocrinology Metabolic SyndromeType 1Diabetes ManagementHealth PolicyCardiovascular Disease | 2017 | 286 |
2014 | 250 | |
2021 | 203 | |
2018 | 179 | |
2015 | 177 | |
2015 | 159 | |
2020 | 141 | |
2013 | 132 |
Page 1
Page 1